Results 191 to 200 of about 988,752 (341)

Rare Movement Disorders-An Approach for Clinicians. [PDF]

open access: yesInt J Mol Sci
Jesuthasan A   +3 more
europepmc   +1 more source

Remote Assessment of Ataxia Severity in SCA3 Across Multiple Centers and Time Points

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Spinocerebellar ataxia type 3 (SCA3) is a genetically defined ataxia. The Scale for Assessment and Rating of Ataxia (SARA) is a clinician‐reported outcome that measures ataxia severity at a single time point. In its standard application, SARA fails to capture short‐term fluctuations, limiting its sensitivity in trials.
Marcus Grobe‐Einsler   +20 more
wiley   +1 more source

Movement Disorders and Oculomotor Abnormalities in Whipple's Disease: An Updated Systematic Review. [PDF]

open access: yesTremor Other Hyperkinet Mov (N Y)
Maslias E   +4 more
europepmc   +1 more source

Reduction of Short-Chain Fatty Acid-Producing Gut Microbiota Leads to Transition from Rapid-Eye-Movement Sleep Behavior Disorder to Parkinson’s Disease [PDF]

open access: gold, 2020
Hiroshi Nishiwaki   +13 more
openalex   +1 more source

Clustering Algorithm Reveals Dopamine‐Motor Mismatch in Cognitively Preserved Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the relationship between dopaminergic denervation and motor impairment in two de novo Parkinson's disease (PD) cohorts. Methods n = 249 PD patients from Parkinson's Progression Markers Initiative (PPMI) and n = 84 from an external clinical cohort.
Rachele Malito   +14 more
wiley   +1 more source

Cerebellar and extra-cerebellar symptoms in movement disorders. [PDF]

open access: yesArq Neuropsiquiatr
Boone DL   +4 more
europepmc   +1 more source

Remote control of movement disorders using a photoactive adenosine A2A receptor antagonist

open access: bronze, 2018
Jaume Taura   +8 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy